Keyphrases
Adaptation
26%
AIDS/HIV
36%
Antiretroviral Therapy
36%
Aqueous Solution
22%
Astrocytes
59%
Bystander Damage
18%
Cancer Pathogenesis
20%
Cell-cell Communication
33%
Central Nervous System
23%
Channel Opening
24%
Communication Systems
23%
Connexin
36%
Connexin Channels
25%
Correlative Imaging
18%
Correlative Light-electron Microscopy
18%
COVID-19
54%
COVID-19 Pathogenesis
19%
Extracellular ATP (eATP)
18%
Fluorescence Spectra
22%
Focused Ion Beam
18%
Gap Junction
48%
Glioblastoma
47%
Glioblastoma Cells
20%
HIV Infection
70%
HIV Patients
54%
HIV Reservoir
39%
HIV-associated
24%
Human Immunodeficiency Virus Type 1 (HIV-1)
39%
Immune Cells
20%
In Cancer
36%
Inositol Phosphate Metabolism
18%
Laser Capture Microdissection
21%
Macrophages
36%
Molecular Fluorescence
18%
Naphthoxazole
18%
NeuroHIV
21%
Novel Therapeutics
18%
Organelle Interaction
18%
Pannexin 1 (Panx1)
24%
Pannexin Channels
66%
Pathological Conditions
18%
Photophysics
36%
Synaptic
18%
Therapeutic Potential
18%
Treatment Resistance
21%
Tumor
36%
Tunneling Nanotubes
100%
Viral
25%
Viral Reservoir
70%
Virus
23%
Medicine and Dentistry
Adenosine
6%
Astrocyte
18%
Cell Adhesion Proteins
9%
Cell Communication
27%
Cell Interaction
9%
Connexin
18%
COVID-19
54%
Cryoelectron Microscopy
18%
DNA Methyltransferase
9%
Electron Microscopy
18%
Exosome
18%
Focused Ion Beam
18%
Gap Junction
21%
Glioblastoma
36%
Homeostasis
9%
Human Immunodeficiency Virus
59%
Human Immunodeficiency Virus Infection
20%
Hypoxia
18%
Imaging Mass Spectrometry
18%
Immune Response
24%
In Vitro
7%
Infection
23%
Inositol Phosphate
18%
Laser Capture Microdissection
20%
Lipidomics
18%
Lung
39%
Malignant Neoplasm
21%
Mass Spectrometry Imaging
18%
Mediator
9%
Megakaryocyte
18%
Nanotube
45%
Neoplasm
21%
Pathogen
18%
Pathophysiology
18%
Phosphate Metabolism
18%
Platelet
18%
Programmed Cell Death
7%
Proteomics
18%
Radiation Therapy
21%
Radiation Treatment
18%
Scanning Transmission Electron Microscopy
18%
Severe Acute Respiratory Syndrome Coronavirus 2
54%
Signaling Molecule
9%
Syncytium
9%
T-Helper Cell
9%
Temozolomide
21%
Tumour Heterogeneity
18%
Virus
14%
Virus Latency
18%
Virus RNA
9%